Previous 10 | Next 10 |
home / stock / cbiif / cbiif news
TORONTO, March 30, 2020 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence driven from the point-of-care to the medical cannabis community, has launched the med...
TORONTO, Jan. 29, 2020 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence driven from the point-of-care to the medical cannabis community, is pleased to announc...
TORONTO, Jan. 27, 2020 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence driven from the point-of-care to the medical cannabis community, announces it has comp...
Partnership Underway to Develop Extensive Protocols and Submissions for US Food & Drug Administration to Uncover Safety and Efficacy for Targeted Medical Cannabis Treatments in the US CB2 chosen to advance application with the US FDA for study on safety and efficacy of cannabis-ba...
TORONTO, Jan. 08, 2020 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence driven from the point-of-care to the medical cannabis community, today released its CE...
Prospective trial marks first-of-its-kind study on the efficacy and safety of hemp-based CBD treatment focused on patients with anxiety Announcement follows the passage of the 2018 US Farm Bill which legalized the mass production of hemp, a form of cannabis with lower THC levels than mari...
Licensed Producers and Multi-State Operators are recognizing the volumes of data they hold from production, retail, medical and product information but currently exist on disparate platforms across multiple geographies. Company completes full-scale platform development for a cloud-based ...
TORONTO, Dec. 11, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“ CB2 ” or the “ Compan y ”), a leading data-driven company focused on bringing real-world evidence-driven from the point-26of-care to the medical cannabis community, announ...
TORONTO, Dec. 03, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence-driven from the point-of-care to the medical cannabis community, today announced that ...
Point Roberts, WA and Delta, BC - November 15, 2019 (Investorideas.com Newswire) Investorideas.com , a global news source and leading investor resource announces its weekly roundup of stocks added to its global stock directories in mining, cannabis, food & beverage, greentech, and cyberse...
News, Short Squeeze, Breakout and More Instantly...
Skylight Health Group Company Name:
CBIIF Stock Symbol:
OTCMKTS Market:
Skylight Health Group Website:
There are over 40 million Americans who are either uninsured or underinsured 1 Over 58 million Americans cannot afford prescription drugs 2 Skylight will provide a discount drug card program to save up to 80% of the cost of generic drugs This program will be a strong...
Skylight Health has been granted conditional approval for listing on the TSX Venture Exchange Company expects to commence trading on the TSX Venture in January 2021 Company will continue to trade under the symbol “SHG” on the TSX Venture TORONTO, Dec. 15, 202...
Florida based primary and urgent care clinic group is an established medical practice. In 2019, the clinic generated CAD 5 million in revenues and CAD 1.2 in EBITDA. Skylight Health’s forecasted annual run rate to now be over CAD 25 million combined with the completion of...